应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
ETNB 89Bio, Inc.
未开盘 07-17 16:00:00 EDT
10.65
+0.02
+0.19%
盘后
10.65
+0.00
0.00%
18:18 EDT
最高
10.85
最低
10.60
成交量
95.55万
今开
10.69
昨收
10.63
日振幅
2.33%
总市值
15.55亿
流通市值
10.82亿
总股本
1.46亿
成交额
1,022万
换手率
0.94%
流通股本
1.02亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
资讯
新帖
简况
89Bio, Inc.盘中异动 早盘股价大涨5.40%报10.26美元
市场透视 · 07-02
89Bio, Inc.盘中异动 早盘股价大涨5.40%报10.26美元
89Bio, Inc.盘中异动 下午盘急速跳水5.19%
市场透视 · 06-16
89Bio, Inc.盘中异动 下午盘急速跳水5.19%
89Bio, Inc.盘中异动 急速下挫5.03%报9.54美元
市场透视 · 06-12
89Bio, Inc.盘中异动 急速下挫5.03%报9.54美元
89Bio, Inc.盘中异动 临近午盘快速上涨5.09%报9.70美元
市场透视 · 05-29
89Bio, Inc.盘中异动 临近午盘快速上涨5.09%报9.70美元
89Bio, Inc.盘中异动 快速拉升5.06%报8.09美元
市场透视 · 05-20
89Bio, Inc.盘中异动 快速拉升5.06%报8.09美元
89Bio, Inc.盘中异动 大幅跳水5.06%报7.79美元
市场透视 · 05-15
89Bio, Inc.盘中异动 大幅跳水5.06%报7.79美元
89Bio, Inc.盘中异动 快速上涨5.13%报8.20美元
市场透视 · 05-14
89Bio, Inc.盘中异动 快速上涨5.13%报8.20美元
89Bio, Inc.盘中异动 早盘急速拉升5.45%报8.12美元
市场透视 · 05-12
89Bio, Inc.盘中异动 早盘急速拉升5.45%报8.12美元
89Bio, Inc.盘中异动 下午盘急速上涨5.03%报7.93美元
市场透视 · 04-30
89Bio, Inc.盘中异动 下午盘急速上涨5.03%报7.93美元
89Bio, Inc.盘中异动 大幅上涨5.40%
市场透视 · 04-28
89Bio, Inc.盘中异动 大幅上涨5.40%
89Bio, Inc.盘中异动 大幅上涨5.97%报5.86美元
市场透视 · 04-14
89Bio, Inc.盘中异动 大幅上涨5.97%报5.86美元
89Bio, Inc.盘中异动 股价大跌5.10%报7.45美元
市场透视 · 03-10
89Bio, Inc.盘中异动 股价大跌5.10%报7.45美元
89Bio, Inc.2024财年实现净利润-3.67亿美元,同比减少158.45%
市场透视 · 03-08
89Bio, Inc.2024财年实现净利润-3.67亿美元,同比减少158.45%
HC Wainwright & Co.:重申89bio(ETNB.US)评级,由买入调整至买入评级, 目标价由29.00美元调整至21.00美元。
金融界 · 02-28
HC Wainwright & Co.:重申89bio(ETNB.US)评级,由买入调整至买入评级, 目标价由29.00美元调整至21.00美元。
89bio(ETNB.US):2024年Q4财报实现营收0美元,前值为0美元;每股收益为-1.02美元,前值为-0.50美元,预期值为-0.73美元。
金融界 · 02-27
89bio(ETNB.US):2024年Q4财报实现营收0美元,前值为0美元;每股收益为-1.02美元,前值为-0.50美元,预期值为-0.73美元。
89bio 2024年第四季度GAAP每股收益$(1.02),低于$(0.77)的预期
财报速递 · 02-27
89bio 2024年第四季度GAAP每股收益$(1.02),低于$(0.77)的预期
89Bio, Inc.盘中异动 大幅上涨5.21%
市场透视 · 02-27
89Bio, Inc.盘中异动 大幅上涨5.21%
89Bio, Inc.盘中异动 早盘股价大跌5.03%报9.62美元
市场透视 · 02-25
89Bio, Inc.盘中异动 早盘股价大跌5.03%报9.62美元
89Bio, Inc.盘中异动 早盘大幅下跌5.06%
市场透视 · 02-24
89Bio, Inc.盘中异动 早盘大幅下跌5.06%
89Bio, Inc.盘中异动 股价大涨5.40%报11.33美元
市场透视 · 02-05
89Bio, Inc.盘中异动 股价大涨5.40%报11.33美元
加载更多
公司概况
公司名称:
89Bio, Inc.
所属市场:
NASDAQ
上市日期:
--
主营业务:
89bio, Inc.于2019年6月作为一家特拉华州公司成立,以经营2018年1月在以色列注册成立的89Bio有限公司的业务。该公司是一家临床阶段的生物制药公司,专注于治疗肝脏和心脏代谢疾病的创新疗法的开发和商业化。公司主导候选产品pegozafermin是一种专门设计的成纤维细胞生长因子的糖聚乙二醇化类似物,目前正在开发用于治疗非酒精性脂肪性肝炎和用于治疗严重的高甘油三酯血症。
发行价格:
--
{"stockData":{"symbol":"ETNB","market":"US","secType":"STK","nameCN":"89Bio, Inc.","latestPrice":10.65,"timestamp":1752782400000,"preClose":10.63,"halted":0,"volume":955504,"hourTrading":{"tag":"盘后","latestPrice":10.65,"preClose":10.65,"latestTime":"18:18 EDT","volume":36132,"amount":384809.3,"timestamp":1752790700710},"delay":0,"floatShares":101584757,"shares":145984182,"eps":-3.295203,"marketStatus":"未开盘","change":0.02,"latestTime":"07-17 16:00:00 EDT","open":10.69,"high":10.8475,"low":10.6,"amount":10220258.062784001,"amplitude":0.023283,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-3.295203,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1752825600000},"marketStatusCode":0,"adr":0,"listingDate":1573448400000,"exchange":"NASDAQ","adjPreClose":10.63,"preHourTrading":{"tag":"盘前","latestPrice":10.7,"preClose":10.63,"latestTime":"09:06 EDT","volume":460,"amount":4912.23972,"timestamp":1752757594137},"postHourTrading":{"tag":"盘后","latestPrice":10.65,"preClose":10.65,"latestTime":"18:18 EDT","volume":36132,"amount":384809.3,"timestamp":1752790700710},"volumeRatio":0.805567,"impliedVol":0.8098,"impliedVolPercentile":0.628},"requestUrl":"/m/hq/s/ETNB","defaultTab":"news","newsList":[{"id":"2548151148","title":"89Bio, Inc.盘中异动 早盘股价大涨5.40%报10.26美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2548151148","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548151148?lang=zh_cn&edition=full","pubTime":"2025-07-02 23:01","pubTimestamp":1751468495,"startTime":"0","endTime":"0","summary":"北京时间2025年07月02日23时01分,89Bio, Inc.股票出现异动,股价急速拉升5.40%。截至发稿,该股报10.26美元/股,成交量49.4276万股,换手率0.34%,振幅6.58%。89Bio, Inc.股票所在的生物技术行业中,整体涨幅为0.82%。89Bio, Inc.公司简介:89bio Inc 是一家总部位于美国的临床阶段生物制药公司,专注于肝脏和心脏代谢疾病疗法的开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025070223013597976bf5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025070223013597976bf5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ETNB","BK4585"],"gpt_icon":0},{"id":"2544602548","title":"89Bio, Inc.盘中异动 下午盘急速跳水5.19%","url":"https://stock-news.laohu8.com/highlight/detail?id=2544602548","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2544602548?lang=zh_cn&edition=full","pubTime":"2025-06-17 01:11","pubTimestamp":1750093896,"startTime":"0","endTime":"0","summary":"北京时间2025年06月17日01时11分,89Bio, Inc.股票出现波动,股价大幅跳水5.19%。截至发稿,该股报9.87美元/股,成交量74.148万股,换手率0.51%,振幅6.13%。89Bio, Inc.股票所在的生物技术行业中,整体跌幅为0.64%。89Bio, Inc.公司简介:89bio Inc 是一家总部位于美国的临床阶段生物制药公司,专注于肝脏和心脏代谢疾病疗法的开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250617011136a4ac88bd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250617011136a4ac88bd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4585","ETNB"],"gpt_icon":0},{"id":"2543454974","title":"89Bio, Inc.盘中异动 急速下挫5.03%报9.54美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2543454974","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2543454974?lang=zh_cn&edition=full","pubTime":"2025-06-13 01:41","pubTimestamp":1749750079,"startTime":"0","endTime":"0","summary":"北京时间2025年06月13日01时41分,89Bio, Inc.股票出现波动,股价大幅跳水5.03%。截至发稿,该股报9.54美元/股,成交量279.07万股,换手率1.91%,振幅4.47%。89Bio, Inc.股票所在的生物技术行业中,整体涨幅为0.61%。89Bio, Inc.公司简介:89bio Inc 是一家总部位于美国的临床阶段生物制药公司,专注于肝脏和心脏代谢疾病疗法的开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250613014120a4a5a456&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250613014120a4a5a456&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ETNB","BK4139","BK4585"],"gpt_icon":0},{"id":"2539264433","title":"89Bio, Inc.盘中异动 临近午盘快速上涨5.09%报9.70美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2539264433","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2539264433?lang=zh_cn&edition=full","pubTime":"2025-05-29 23:31","pubTimestamp":1748532702,"startTime":"0","endTime":"0","summary":"北京时间2025年05月29日23时31分,89Bio, Inc.股票出现波动,股价大幅拉升5.09%。截至发稿,该股报9.70美元/股,成交量32.3953万股,换手率0.22%,振幅6.12%。89Bio, Inc.股票所在的生物技术行业中,整体涨幅为1.37%。89Bio, Inc.公司简介:89bio Inc 是一家总部位于美国的临床阶段生物制药公司,专注于肝脏和心脏代谢疾病疗法的开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250529233142a6f20e6c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250529233142a6f20e6c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4585","BK4139","ETNB"],"gpt_icon":0},{"id":"2537427926","title":"89Bio, Inc.盘中异动 快速拉升5.06%报8.09美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2537427926","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2537427926?lang=zh_cn&edition=full","pubTime":"2025-05-21 01:11","pubTimestamp":1747761088,"startTime":"0","endTime":"0","summary":"北京时间2025年05月21日01时11分,89Bio, Inc.股票出现异动,股价快速拉升5.06%。截至发稿,该股报8.09美元/股,成交量49.0713万股,换手率0.34%,振幅6.36%。89Bio, Inc.股票所在的生物技术行业中,整体涨幅为0.39%。89Bio, Inc.公司简介:89bio Inc 是一家总部位于美国的临床阶段生物制药公司,专注于肝脏和心脏代谢疾病疗法的开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250521011128a6e65108&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250521011128a6e65108&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4585","ETNB","BK4139"],"gpt_icon":0},{"id":"2535829036","title":"89Bio, Inc.盘中异动 大幅跳水5.06%报7.79美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2535829036","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2535829036?lang=zh_cn&edition=full","pubTime":"2025-05-15 21:57","pubTimestamp":1747317450,"startTime":"0","endTime":"0","summary":"北京时间2025年05月15日21时57分,89Bio, Inc.股票出现异动,股价快速下挫5.06%。截至发稿,该股报7.79美元/股,成交量5.6241万股,换手率0.04%,振幅4.51%。89Bio, Inc.股票所在的生物技术行业中,整体涨幅为0.47%。89Bio, Inc.公司简介:89bio Inc 是一家总部位于美国的临床阶段生物制药公司,专注于肝脏和心脏代谢疾病疗法的开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250515215730a6e0741f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250515215730a6e0741f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ETNB","BK4585"],"gpt_icon":0},{"id":"2535707843","title":"89Bio, Inc.盘中异动 快速上涨5.13%报8.20美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2535707843","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2535707843?lang=zh_cn&edition=full","pubTime":"2025-05-14 21:36","pubTimestamp":1747229787,"startTime":"0","endTime":"0","summary":"北京时间2025年05月14日21时36分,89Bio, Inc.股票出现异动,股价急速拉升5.13%。截至发稿,该股报8.20美元/股,成交量10.2479万股,换手率0.07%,振幅3.85%。89Bio, Inc.股票所在的生物技术行业中,整体涨幅为0.23%。89Bio, Inc.公司简介:89bio Inc 是一家总部位于美国的临床阶段生物制药公司,专注于肝脏和心脏代谢疾病疗法的开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025051421362797598710&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025051421362797598710&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4585","ETNB"],"gpt_icon":0},{"id":"2534279157","title":"89Bio, Inc.盘中异动 早盘急速拉升5.45%报8.12美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2534279157","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2534279157?lang=zh_cn&edition=full","pubTime":"2025-05-12 21:30","pubTimestamp":1747056623,"startTime":"0","endTime":"0","summary":"北京时间2025年05月12日21时30分,89Bio, Inc.股票出现异动,股价大幅上涨5.45%。截至发稿,该股报8.12美元/股,成交量6979股,换手率0.00%,振幅0.00%。89Bio, Inc.股票所在的生物技术行业中,整体涨幅为0.00%。89Bio, Inc.公司简介:89bio Inc 是一家总部位于美国的临床阶段生物制药公司,专注于肝脏和心脏代谢疾病疗法的开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250512213024a47b75cd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250512213024a47b75cd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ETNB","BK4139","BK4585"],"gpt_icon":0},{"id":"2532064526","title":"89Bio, Inc.盘中异动 下午盘急速上涨5.03%报7.93美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2532064526","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2532064526?lang=zh_cn&edition=full","pubTime":"2025-05-01 02:21","pubTimestamp":1746037264,"startTime":"0","endTime":"0","summary":"北京时间2025年05月01日02时21分,89Bio, Inc.股票出现波动,股价大幅拉升5.03%。截至发稿,该股报7.93美元/股,成交量97.3468万股,换手率0.67%,振幅6.29%。89Bio, Inc.股票所在的生物技术行业中,整体涨幅为1.35%。89Bio, Inc.公司简介:89bio Inc 是一家总部位于美国的临床阶段生物制药公司,专注于肝脏和心脏代谢疾病疗法的开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250501022105a6cf2814&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250501022105a6cf2814&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ETNB","BK4585","BK4139"],"gpt_icon":0},{"id":"2530223645","title":"89Bio, Inc.盘中异动 大幅上涨5.40%","url":"https://stock-news.laohu8.com/highlight/detail?id=2530223645","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2530223645?lang=zh_cn&edition=full","pubTime":"2025-04-28 21:43","pubTimestamp":1745847816,"startTime":"0","endTime":"0","summary":"北京时间2025年04月28日21时43分,89Bio, Inc.股票出现波动,股价大幅拉升5.40%。截至发稿,该股报7.32美元/股,成交量9.4096万股,换手率0.06%,振幅4.90%。89Bio, Inc.股票所在的生物技术行业中,整体涨幅为0.78%。89Bio, Inc.公司简介:89bio Inc 是一家总部位于美国的临床阶段生物制药公司,专注于肝脏和心脏代谢疾病疗法的开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250428214336a6cbc311&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250428214336a6cbc311&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4585","ETNB"],"gpt_icon":0},{"id":"2527164173","title":"89Bio, Inc.盘中异动 大幅上涨5.97%报5.86美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2527164173","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2527164173?lang=zh_cn&edition=full","pubTime":"2025-04-14 21:30","pubTimestamp":1744637443,"startTime":"0","endTime":"0","summary":"北京时间2025年04月14日21时30分,89Bio, Inc.股票出现波动,股价快速上涨5.97%。截至发稿,该股报5.86美元/股,成交量3.6872万股,换手率0.03%,振幅0.00%。89Bio, Inc.股票所在的生物技术行业中,整体涨幅为0.00%。89Bio, Inc.公司简介:89bio Inc 是一家总部位于美国的临床阶段生物制药公司,专注于肝脏和心脏代谢疾病疗法的开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202504142130449737831d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202504142130449737831d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4585","ETNB","BK4139"],"gpt_icon":0},{"id":"2518703262","title":"89Bio, Inc.盘中异动 股价大跌5.10%报7.45美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2518703262","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518703262?lang=zh_cn&edition=full","pubTime":"2025-03-10 21:47","pubTimestamp":1741614433,"startTime":"0","endTime":"0","summary":"北京时间2025年03月10日21时47分,89Bio, Inc.股票出现波动,股价快速跳水5.10%。截至发稿,该股报7.45美元/股,成交量9.118万股,换手率0.06%,振幅3.95%。89Bio, Inc.股票所在的生物技术行业中,整体涨幅为0.30%。89Bio, Inc.公司简介:89bio Inc 是一家总部位于美国的临床阶段生物制药公司,专注于肝脏和心脏代谢疾病疗法的开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310214713abf30247&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310214713abf30247&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4585","ETNB"],"gpt_icon":0},{"id":"2518440673","title":"89Bio, Inc.2024财年实现净利润-3.67亿美元,同比减少158.45%","url":"https://stock-news.laohu8.com/highlight/detail?id=2518440673","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518440673?lang=zh_cn&edition=full","pubTime":"2025-03-09 00:00","pubTimestamp":1741449623,"startTime":"0","endTime":"0","summary":"3月9日,89Bio, Inc.公布财报,公告显示公司2024财年净利润为-3.67亿美元,同比减少158.45%;其中营业收入为0.00美元,每股基本收益为-3.51美元。从资产负债表来看,89Bio, Inc.总负债77.90百万美元,其中短期债务727000.00美元,资产负债比为0.07,流动比率为0.14。机构评级:截至2025年3月9日,当前有9家机构对89Bio, Inc.目标价做出预测,其中目标均价为29.67美元,其中最低目标价为12.00美元,最高目标价为51.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250309000038abef9700&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250309000038abef9700&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ETNB"],"gpt_icon":0},{"id":"2516311371","title":"HC Wainwright & Co.:重申89bio(ETNB.US)评级,由买入调整至买入评级, 目标价由29.00美元调整至21.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2516311371","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516311371?lang=zh_cn&edition=full","pubTime":"2025-03-01 00:21","pubTimestamp":1740759694,"startTime":"0","endTime":"0","summary":"HC Wainwright & Co.:重申89bio(ETNB.US)评级,由买入调整至买入评级, 目标价由29.00美元调整至21.00美元。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/03/01002148469142.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["ETNB"],"gpt_icon":0},{"id":"2514354518","title":"89bio(ETNB.US):2024年Q4财报实现营收0美元,前值为0美元;每股收益为-1.02美元,前值为-0.50美元,预期值为-0.73美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2514354518","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514354518?lang=zh_cn&edition=full","pubTime":"2025-02-28 07:08","pubTimestamp":1740697717,"startTime":"0","endTime":"0","summary":"89bio(ETNB.US):2024年Q4财报实现营收0美元,前值为0美元;每股收益为-1.02美元,前值为-0.50美元,预期值为-0.73美元。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/02/28070848442545.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["ETNB"],"gpt_icon":0},{"id":"1145283862","title":"89bio 2024年第四季度GAAP每股收益$(1.02),低于$(0.77)的预期","url":"https://stock-news.laohu8.com/highlight/detail?id=1145283862","media":"财报速递","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1145283862?lang=zh_cn&edition=full","pubTime":"2025-02-28 05:46","pubTimestamp":1740692807,"startTime":"0","endTime":"0","summary":"89bio 报告的季度亏损为每股$,低于分析师共识预期的$,低32.47%。与去年同期每股亏损$相比,减少了104%。以上内容来自Benzinga Earnings专栏,原文如下:89bio reported quarterly losses of $ per share which missed the analyst consensus estimate of $ by 32.47 percent. This is a 104 percent decrease over losses of $ per share from the same period last year.","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"89bio 2024年第四季度GAAP每股收益$(1.02),低于$(0.77)的预期","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ETNB"],"gpt_icon":0},{"id":"2514389295","title":"89Bio, Inc.盘中异动 大幅上涨5.21%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514389295","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514389295?lang=zh_cn&edition=full","pubTime":"2025-02-27 23:13","pubTimestamp":1740669233,"startTime":"0","endTime":"0","summary":"北京时间2025年02月27日23时13分,89Bio, Inc.股票出现异动,股价急速拉升5.21%。截至发稿,该股报9.69美元/股,成交量23.3454万股,换手率0.16%,振幅5.81%。89Bio, Inc.股票所在的生物技术行业中,整体涨幅为0.97%。89Bio, Inc.公司简介:89bio Inc 是一家总部位于美国的临床阶段生物制药公司,专注于肝脏和心脏代谢疾病疗法的开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250227231353a256852e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250227231353a256852e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ETNB","BK4585","BK4139"],"gpt_icon":0},{"id":"2514801307","title":"89Bio, Inc.盘中异动 早盘股价大跌5.03%报9.62美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514801307","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514801307?lang=zh_cn&edition=full","pubTime":"2025-02-25 23:22","pubTimestamp":1740496952,"startTime":"0","endTime":"0","summary":"北京时间2025年02月25日23时22分,89Bio, Inc.股票出现异动,股价快速下跌5.03%。截至发稿,该股报9.62美元/股,成交量30.4897万股,换手率0.21%,振幅4.77%。89Bio, Inc.股票所在的生物技术行业中,整体涨幅为0.70%。89Bio, Inc.公司简介:89bio Inc 是一家总部位于美国的临床阶段生物制药公司,专注于肝脏和心脏代谢疾病疗法的开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225232232abdc8b43&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225232232abdc8b43&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4585","BK4139","ETNB"],"gpt_icon":0},{"id":"2513384720","title":"89Bio, Inc.盘中异动 早盘大幅下跌5.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2513384720","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2513384720?lang=zh_cn&edition=full","pubTime":"2025-02-24 23:03","pubTimestamp":1740409380,"startTime":"0","endTime":"0","summary":"北京时间2025年02月24日23时03分,89Bio, Inc.股票出现波动,股价快速跳水5.06%。截至发稿,该股报10.50美元/股,成交量11.5698万股,换手率0.08%,振幅5.47%。89Bio, Inc.股票所在的生物技术行业中,整体涨幅为0.24%。89Bio, Inc.公司简介:89bio Inc 是一家总部位于美国的临床阶段生物制药公司,专注于肝脏和心脏代谢疾病疗法的开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224230300962ea0b5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224230300962ea0b5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4585","BK4139","ETNB"],"gpt_icon":0},{"id":"2509280422","title":"89Bio, Inc.盘中异动 股价大涨5.40%报11.33美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2509280422","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2509280422?lang=zh_cn&edition=full","pubTime":"2025-02-05 23:15","pubTimestamp":1738768527,"startTime":"0","endTime":"0","summary":"北京时间2025年02月05日23时15分,89Bio, Inc.股票出现波动,股价大幅上涨5.40%。截至发稿,该股报11.33美元/股,成交量46.3866万股,换手率0.32%,振幅5.35%。89Bio, Inc.股票所在的生物技术行业中,整体涨幅为1.22%。89Bio, Inc.公司简介:89bio Inc 是一家总部位于美国的临床阶段生物制药公司,专注于肝脏和心脏代谢疾病疗法的开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250205231528987b8407&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250205231528987b8407&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4585","ETNB","BK4139"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.89bio.com","stockEarnings":[{"period":"1week","weight":-0.0121},{"period":"1month","weight":0.0714},{"period":"3month","weight":0.7574},{"period":"6month","weight":0.6878},{"period":"1year","weight":0.227},{"period":"ytd","weight":0.3619}],"compareEarnings":[{"period":"1week","weight":0.0035},{"period":"1month","weight":0.0511},{"period":"3month","weight":0.1931},{"period":"6month","weight":0.051},{"period":"1year","weight":0.1277},{"period":"ytd","weight":0.0716}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"89bio, Inc.于2019年6月作为一家特拉华州公司成立,以经营2018年1月在以色列注册成立的89Bio有限公司的业务。该公司是一家临床阶段的生物制药公司,专注于治疗肝脏和心脏代谢疾病的创新疗法的开发和商业化。公司主导候选产品pegozafermin是一种专门设计的成纤维细胞生长因子的糖聚乙二醇化类似物,目前正在开发用于治疗非酒精性脂肪性肝炎和用于治疗严重的高甘油三酯血症。","yearOnYearQuotes":[{"month":1,"riseRate":0.333333,"avgChangeRate":-0.111427},{"month":2,"riseRate":0.666667,"avgChangeRate":0.102838},{"month":3,"riseRate":0.333333,"avgChangeRate":-0.098837},{"month":4,"riseRate":0.5,"avgChangeRate":-0.083264},{"month":5,"riseRate":0.666667,"avgChangeRate":0.08296},{"month":6,"riseRate":0.5,"avgChangeRate":-0.019291},{"month":7,"riseRate":0.666667,"avgChangeRate":0.088038},{"month":8,"riseRate":1,"avgChangeRate":0.16496},{"month":9,"riseRate":0.4,"avgChangeRate":-0.059438},{"month":10,"riseRate":0.4,"avgChangeRate":-0.003798},{"month":11,"riseRate":0.6,"avgChangeRate":-0.000698},{"month":12,"riseRate":0.333333,"avgChangeRate":0.097135}],"exchange":"NASDAQ","name":"89Bio, Inc.","nameEN":"89Bio, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.34.3","shortVersion":"4.34.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"89Bio, Inc.(ETNB)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供89Bio, Inc.(ETNB)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"89Bio, Inc.,ETNB,89Bio, Inc.股票,89Bio, Inc.股票老虎,89Bio, Inc.股票老虎国际,89Bio, Inc.行情,89Bio, Inc.股票行情,89Bio, Inc.股价,89Bio, Inc.股市,89Bio, Inc.股票价格,89Bio, Inc.股票交易,89Bio, Inc.股票购买,89Bio, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"89Bio, Inc.(ETNB)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供89Bio, Inc.(ETNB)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}